Details for New Drug Application (NDA): 215000
✉ Email this page to a colleague
The generic ingredient in CARMUSTINE is carmustine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for 215000
Tradename: | CARMUSTINE |
Applicant: | Accord Hlthcare |
Ingredient: | carmustine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215000
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | May 16, 2022 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 300MG/VIAL | ||||
Approval Date: | May 16, 2022 | TE: | RLD: | Yes |
Complete Access Available with Subscription